SEC 13F Intelligence

Exome Asset Management LLC / RYTM

Exome Asset Management LLC’s Rhythm Pharmaceuticals Inc Position

Does Exome Asset Management LLC own Rhythm Pharmaceuticals Inc (RYTM)? Yes40.6K shares worth $4M (+1.83% of its 13F portfolio) as of Q1 2026, down from 45.6K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
40.6K
% of Portfolio
+1.83%
Quarters Held
3
currently held

Position History RYTM

Reported value by quarter
Q4 ’23: $3MQ4 ’23Q1 ’24: $2MQ1 ’24Q1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202640.6K$4M+1.83%
Q1 202445.6K$2M+1.69%
Q4 202372.2K$3M+3.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exome Asset Management LLC’s full portfolio or all institutional holders of RYTM.